You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CPD

Practical Considerations for Effective Use of Neutralizing Antibodies to Treat COVID-19

  • Authors: José R. Arribas, MD; Christoph Spinner, MD
  • CPD Released: 6/10/2022
  • Valid for credit through: 6/10/2023
Start Activity

  • Credits Available

    Non-US Physicians - maximum of 0.50 CPD

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US primary care physicians, infectious disease/HIV specialists, and pulmonologists.

The goal of this activity is for clinicians to be more knowledgeable about the latest data on and practical considerations for effectively using monoclonal antibodies (mAbs) in clinical practice.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding
    • Recent advances in mAbs for the treatment of COVID-19
    • Current limitations of mAbs for the treatment of COVID-19
  • Have greater competence related to
    • Appropriate use of mAbs to treat COVID-19


Disclosures

WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.


Faculty

  • José R. Arribas, MD

    Associate Professor
    Infectious Diseases
    Faculty of Medicine
    Autonomous University of Madrid
    Research Director
    HIV and Infectious Diseases Unit
    Hospital La Paz Institute for Health Research (IdiPAZ)
    Madrid, Spain

    Disclosures

    José R. Arribas, MD has the following relevant financial relationships:
    Grants for clinical research from: Gilead Sciences, Inc.; ViiV Healthcare
    Advisor or consultant for: Gilead Sciences, Inc.; GlaxoSmithKline; Janssen Pharmaceuticals; Merck Sharp & Dohme; Pfizer; Roche Diagnostics; Thera; ViiV Healthcare
    Speaker or member of speakers bureau for: GlaxoSmithKline; Janssen Pharmaceuticals; Merck Sharp & Dohme; ViiV Healthcare

  • Christoph Spinner, MD

    Consultant Physician in Internal Medicine and Infectious Diseases
    Technical University of Munich
    School of Medicine
    University Hospital Rechts der Isar
    Department of Medicine II
    Munich, Germany

    Disclosures

    Christoph Spinner, MD, has the following relevant financial relationships:
    Independent contractor for: AbbVie Inc.; Apeiron; AstraZeneca Pharmaceuticals LP; GlaxoSmithKline; Janssen Pharmaceuticals-Cilag; Merck Sharp & Dohme; ViiV Healthcare
    Grants for clinical research from: Gilead Sciences, Inc.; Janssen Pharmaceuticals-Cilag; Merck Sharp & Dohme; ViiV Healthcare
    Advisor or consultant for: AbbVie Inc.; AstraZeneca Pharmaceuticals LP; Eli Lilly and Company; GlaxoSmithKline; Gilead Sciences, Inc.; Janssen-Cilag Pharmaceuticals; Merck Sharp & Dohme; SOBI; Synairgen; ViiV Healthcare
    Speaker or member of speakers bureau for: AbbVie Inc.; AstraZeneca Pharmaceuticals LP; GlaxoSmithKline; Janssen-Cilag Pharmaceuticals; Merck Sharp & Dohme; ViiV Healthcare

Editor

  • Shanthi Voorn, PhD

    Medical Education Director, WebMD Global, LLC

    Disclosures

    Shanthi Voorn, PhD, has no relevant financial relationships.

Compliance Reviewer

  • Susan L. Smith, MN, PhD

    Associate Director, Accreditation and Compliance

    Disclosures

    Susan L. Smith, MN, PhD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

    For Physicians

  • The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.50 continuing professional development credits (CPD).

    Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

  1. Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
  2. Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CPD

Practical Considerations for Effective Use of Neutralizing Antibodies to Treat COVID-19

Authors: José R. Arribas, MD; Christoph Spinner, MDFaculty and Disclosures

CPD Released: 6/10/2022

Valid for credit through: 6/10/2023

processing....

Note: The information on the coronavirus outbreak is continually evolving. The content within this activity serves as a historical reference to the information that was available at the time of this publication. We continue to add to the collection of activities on this subject as new information becomes available. It is the policy of Medscape Education to avoid the mention of brand names or specific manufacturers in accredited educational activities. However, manufacturer names related to the approved COVID-19 vaccines are provided in this activity in an effort to promote clarity. The use of manufacturer names should not be viewed as an endorsement by Medscape of any specific product or manufacturer.

Educational Impact Challenge

The goal of this activity is for clinicians to be more knowledgeable about the latest data on and practical considerations for effectively using monoclonal antibodies (mAbs) in clinical practice.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.